Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice

Benson Chellakkan Selvanesan(The University of Texas MD Anderson Cancer Center), Claudia Gravekamp(Albert Einstein College of Medicine)
Journal for ImmunoTherapy of Cancer
November 1, 2020
Cited by 28


Related Papers